Catamount Wealth Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-100
Closed -$5K 235
2018
Q3
$5K Hold
100
﹤0.01% 167
2018
Q2
$6K Hold
100
﹤0.01% 157
2018
Q1
$3K Sell
100
-300
-75% -$9K ﹤0.01% 170
2017
Q4
$7K Sell
400
-750
-65% -$13.1K ﹤0.01% 148
2017
Q3
$13K Buy
+1,150
New +$13K 0.01% 126